One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology

OBJECTIVE: The aim was to study the effect of non-mandatory transitioning from etanercept originator to etanercept biosimilar on retention rates in a setting promoting shared decision-making. METHODS: In 2016, all patients treated with etanercept originator and stable disease at the Rheumatology dep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatol Adv Pract
Main Authors: Müskens, Wieland D, Rongen-van Dartel, Sanne A A, Teerenstra, Steven, Adang, Eddy M M, van Riel, Piet L C M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519774/
https://ncbi.nlm.nih.gov/pubmed/33005860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados